NovoCure Limited (NVCR) Revenue 2017–2026
NovoCure Limited (NVCR) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$655.4MFY2026 · since FY2017: $82.9M → $655.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $655.4M | +8.3% |
| FY2025 | $605.2M | +18.8% |
| FY2024 | $509.3M | -5.3% |
| FY2023 | $537.8M | +0.5% |
| FY2022 | $535.0M | +8.2% |
| FY2021 | $494.4M | +40.7% |
| FY2020 | $351.3M | +41.6% |
| FY2019 | $248.1M | +40.1% |
| FY2018 | $177.0M | +113.6% |
| FY2017 | $82.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice